GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (WBO:HSIC) » Definitions » Capital Expenditure

Henry Schein (WBO:HSIC) Capital Expenditure : €-173.03 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Henry Schein Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Henry Schein's cash flow for capital expenditures for the three months ended in Dec. 2023 was €-72 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was €-173.03 Mil.


Henry Schein Capital Expenditure Historical Data

The historical data trend for Henry Schein's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henry Schein Capital Expenditure Chart

Henry Schein Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -68.60 -40.14 -99.12 -120.83 -171.48

Henry Schein Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.58 -28.95 -34.15 -37.48 -72.44

Henry Schein Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-173.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henry Schein (WBO:HSIC) Business Description

Traded in Other Exchanges
Address
135 Duryea Road, Melville, NY, USA, 11747
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.

Henry Schein (WBO:HSIC) Headlines

From GuruFocus

Q4 2022 Henry Schein Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Henry Schein Inc To Host Investor Meeting Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Henry Schein Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Henry Schein Inc at Nasdaq Investor Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Henry Schein Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Henry Schein Inc at Nasdaq Investor Conference Transcript

By GuruFocus Research 01-23-2024